Division of Sports Medicine, Department of Orthopedic Surgery, Boston Children's Hospital, Boston, Massachusetts, USA.
Department of Orthopedics, Rady Children's Hospital, San Diego, California, USA.
Am J Sports Med. 2022 Sep;50(11):3045-3055. doi: 10.1177/03635465221114420. Epub 2022 Aug 19.
The optimal treatment of midshaft clavicle fractures is controversial. Few previous comparative functional outcome studies have investigated these fractures in adolescents, the most commonly affected epidemiologic subpopulation.
PURPOSE/HYPOTHESIS: The purpose was to prospectively compare the outcomes of operative versus nonoperative treatment in adolescents with completely displaced midshaft clavicle fractures. The study hypothesis was that surgery would yield superior outcomes.
Cohort study; Level of evidence, 2.
Patients aged 10 to 18 years treated for a midshaft clavicle fracture over a 5-year period at 1 of 8 pediatric centers were prospectively screened, with independent treatment decisions determined by individual musculoskeletal professionals. Demographics, radiographic clinical features, complications, and patient-reported outcomes (PROs) were prospectively recorded for 2 years. Regression and matching techniques were utilized to adjust for potential age- and fracture severity-based confounders for creation of comparable subgroups for analysis.
Of 416 adolescents with completely displaced midshaft clavicle fractures, 282 (68) provided 2-year PRO data. Operative patients (n = 88; 31%) demonstrated no difference in sex (78% male) or athletic participation but were older (mean age, 15.2 vs 13.5 years; < .001), had more comminuted fractures (49.4% vs 26.3%; < .001), and had greater fracture shortening (25.5 vs 20.7 mm; < .001) than nonoperative patients (n = 194; 69%). There was no difference in mean PRO scores or rates of "suboptimal" scores (based on threshold values established a priori) between the operative and nonoperative treatment groups (American Shoulder and Elbow Surgeons, 96.8 vs 98.4; shortened version of the Disabilities of the Arm, Shoulder and Hand, 3.0 vs 1.6; EuroQol [EQ] visual analog scale, 93.0 vs 93.9; EQ-5 Dimensions index, 0.96 vs 0.98), even after regression and matching techniques adjusted for confounders. Operative patients had more unexpected subsequent surgery (10.4% vs 1.4%; = .004) and clinically significant complications (20.8% vs 5.2%; = .001). Overall, nonunion (0.4%), delayed union (1.9%), symptomatic malunion (0.4%), and refracture (2.6%) were exceedingly rare, with no difference between treatment groups.
Surgery demonstrated no benefit in patient-reported quality of life, satisfaction, shoulder-specific function, or prevention of complications after completely displaced clavicle shaft fractures in adolescents at 2 years after injury.
NCT04250415 (ClinicalTrials.gov identifier).
锁骨中段骨折的最佳治疗方法存在争议。之前很少有比较功能预后的研究调查过青少年这一最常见的流行病学亚群中的此类骨折。
目的/假设:目的是前瞻性比较手术与非手术治疗完全移位锁骨中段骨折的青少年的结果。研究假设是手术会产生更好的结果。
队列研究;证据水平,2 级。
在 8 家儿科中心的 5 年内,对 10 至 18 岁的锁骨中段骨折患者进行前瞻性筛选,由各骨科专业人员独立决定治疗方案。前瞻性记录了 2 年的人口统计学、影像学临床特征、并发症和患者报告的结果(PRO)。利用回归和匹配技术,对潜在的年龄和骨折严重程度的混杂因素进行调整,为分析创建可比的亚组。
416 例完全移位锁骨中段骨折的青少年中,282 例(68%)提供了 2 年的 PRO 数据。手术组(n=88;31%)的性别(78%为男性)或运动参与率无差异,但年龄较大(平均年龄,15.2 岁比 13.5 岁;<.001),骨折更粉碎(49.4%比 26.3%;<.001),骨折缩短更明显(25.5 毫米比 20.7 毫米;<.001)。与非手术组(n=194;69%)相比,手术组的平均 PRO 评分或“不理想”评分(基于事先确定的阈值)无差异(美国肩肘外科医师学会,96.8 比 98.4;缩短版的上肢残疾量表,3.0 比 1.6;欧洲五维健康量表[EQ]视觉模拟量表,93.0 比 93.9;EQ-5D 维度指数,0.96 比 0.98),即使在调整了混杂因素后,也无差异。手术组有更多意外的后续手术(10.4%比 1.4%;=.004)和临床显著的并发症(20.8%比 5.2%;=.001)。总的来说,非愈合(0.4%)、延迟愈合(1.9%)、症状性愈合不良(0.4%)和再骨折(2.6%)极为罕见,且两组之间无差异。
在受伤后 2 年,手术在改善完全移位锁骨中段骨折青少年患者的生活质量、满意度、肩部特异性功能或预防并发症方面未显示出优势。
NCT04250415(ClinicalTrials.gov 标识符)。